Long-term oncologic and functional outcomes following robot-assisted radical cystectomy and intracorporeal Padua ileal bladder: results from a single high-volume center.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 28 05 2023
accepted: 04 07 2023
medline: 31 8 2023
pubmed: 31 7 2023
entrez: 30 7 2023
Statut: ppublish

Résumé

To report long-term oncologic and functional outcomes of a large consecutive single center series of Robot-assisted radical cystectomy (RARC)- intracorporeal (IC) Urinary Diversion (UD), identifying their predicting factors. A single center Bladder cancer (BC) database was queried for "RARC" and "ICUD", including patients treated between January 2012 and September 2020. Kaplan-Meier curves were assessed disease-free (DFS), cancer-specific (CSS) and overall survival (OS) probability. Univariable (UV) and multivariable (MV) analysis were adopted to identify predictors of DFS, CSS and OS. Kaplan-Meier method evaluated day- and night-time continence recovery probabilities; UV and MV analysis were adopted to identify predictors of Day-time continence. Overall, 251 patients were included. Among them, 192 patients underwent intracorporeal ileal orthotopic neobladder (ION) (76.5%). Five-year DFS, CSS and OS rates were 66.5%, 65.4% and 61.5%; pT stage ≥ 3 and pathologic nodal involvement were identified as negative independent predictors of DFS (HR 2.39, p = 0.001, HR 4.64, p ≤  0.001), CSS (HR 2.20, p = 0.01, HR 3.97, p < 0.001) and OS (HR 2.25, p = 0.005, HR 3.95, p < 0.001). In RARC-ION patients, Trifecta rate was 64.1%. One-year day- and night-time continence rates were 78.6% and 48.3%. Age (HR 0.98, p = 0.03), female gender (HR 0.57, p = 0.008) and complications Clavien grade ≥ 3 (HR 0.55, p = 0.03) were identified as independent predictors of day-time incontinence. Long-term oncologic outcomes and their predicting factors seem aligned to the largest historical open series and multi-institutional robotic series data. According to the identified predicting factors undermining a proper achievement of day-time continence, this represents an objective support, in order to properly advice specific sub-group of patients.

Identifiants

pubmed: 37518504
doi: 10.1007/s00345-023-04523-8
pii: 10.1007/s00345-023-04523-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2359-2366

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Witjes JA, Bruins HM, Cathomas R et al (2021) European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol 79:82–104. https://doi.org/10.1016/j.eururo.2020.03.055
doi: 10.1016/j.eururo.2020.03.055 pubmed: 32360052
Bochner BH, Dalbagni G, Marzouk KH et al (2018) Randomized trial comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: oncologic outcomes. Eur Urol 74:465–471. https://doi.org/10.1016/j.eururo.2018.04.030
doi: 10.1016/j.eururo.2018.04.030 pubmed: 29784190 pmcid: 6697266
Simone G, Tuderti G, Misuraca L et al (2018) Perioperative and mid-term oncologic outcomes of robotic assisted radical cystectomy with totally intracorporeal neobladder: results of a propensity score matched comparison with open cohort from a single-centre series. Eur J Surg Oncol 44:1432–1438. https://doi.org/10.1016/j.ejso.2018.04.006
doi: 10.1016/j.ejso.2018.04.006 pubmed: 29699838
Parekh DJ, Reis IM, Castle EP et al (2018) Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet 391:2525–2536. https://doi.org/10.1016/S0140-6736(18)30996-6
doi: 10.1016/S0140-6736(18)30996-6 pubmed: 29976469
Brassetti A, Cacciamani G, Anceschi U et al (2020) Long-term oncologic outcomes of robot-assisted radical cystectomy (RARC) with totally intracorporeal urinary diversion (ICUD): a multi-center study. World J Urol 38:837–843. https://doi.org/10.1007/s00345-019-02842-3
doi: 10.1007/s00345-019-02842-3 pubmed: 31190152
Cacciamani GE, Rajarubendra N, Artibani W, Gill IS (2019) Robotic intracorporeal urinary diversion: state of the art. Curr Opin Urol 29:293–300. https://doi.org/10.1097/MOU.0000000000000592
doi: 10.1097/MOU.0000000000000592 pubmed: 30762669
Tuderti G, Mastroianni R, Brassetti A et al (2021) Robot-assisted radical cystectomy with intracorporeal neobladder: impact of learning curve and long-term assessment of functional outcomes. Minerva Urol Nephrol 73:754–762. https://doi.org/10.23736/S2724-6051.20.03948-X
doi: 10.23736/S2724-6051.20.03948-X pubmed: 33016028
Simone G, Papalia R, Misuraca L et al (2018) Robotic intracorporeal Padua ileal bladder: surgical technique, perioperative, oncologic and functional outcomes. Eur Urol 73:934–940. https://doi.org/10.1016/j.eururo.2016.10.018
doi: 10.1016/j.eururo.2016.10.018 pubmed: 27780643
Claroni C, Covotta M, Torregiani G et al (2019) Recovery from anesthesia after robotic-assisted radical cystectomy: two different reversals of neuromuscular blockade. J Clin Med 8:1774. https://doi.org/10.3390/jcm8111774
doi: 10.3390/jcm8111774 pubmed: 31653003 pmcid: 6912240
Brassetti A, Tuderti G, Anceschi U et al (2019) Combined reporting of surgical quality, cancer control and functional outcomes of robot-assisted radical cystectomy with intracorporeal orthotopic neobladder into a novel trifecta. Minerva Urol Nefrol 71:590–596. https://doi.org/10.23736/S0393-2249.19.03566-5
doi: 10.23736/S0393-2249.19.03566-5 pubmed: 31619034
Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470. https://doi.org/10.7326/0003-4819-130-6-199903160-00002
doi: 10.7326/0003-4819-130-6-199903160-00002 pubmed: 10075613
Levey AS, Eckardt K-U, Tsukamoto Y et al (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67:2089–2100. https://doi.org/10.1111/j.1523-1755.2005.00365.x
doi: 10.1111/j.1523-1755.2005.00365.x pubmed: 15882252
Yuh B, Wilson T, Bochner B et al (2015) Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy. Eur Urol 67:402–422. https://doi.org/10.1016/j.eururo.2014.12.008
doi: 10.1016/j.eururo.2014.12.008 pubmed: 25560797
Desai MM, Gill IS, de Castro Abreu AL et al (2014) Robotic intracorporeal orthotopic neobladder during radical cystectomy in 132 patients. J Urol 192:1734–1740. https://doi.org/10.1016/j.juro.2014.06.087
doi: 10.1016/j.juro.2014.06.087 pubmed: 25016136
Presicce F, Leonardo C, Tuderti G et al (2021) Late complications of robot-assisted radical cystectomy with totally intracorporeal urinary diversion. World J Urol 39:1903–1909. https://doi.org/10.1007/s00345-020-03378-7
doi: 10.1007/s00345-020-03378-7 pubmed: 32747981
Tuderti G, Brassetti A, Minisola F et al (2019) Transnephrostomic indocyanine green-guided robotic ureteral reimplantation for benign ureteroileal strictures after robotic cystectomy and intracorporeal neobladder: step-by-step surgical technique, perioperative and functional outcomes. J Endourol 33:823–828. https://doi.org/10.1089/end.2019.0376
doi: 10.1089/end.2019.0376 pubmed: 31397180
Ghodoussipour S, Ahmadi N, Goh A et al (2022) Robotic repair of ureteroenteric stricture following radical cystectomy: a multi-institutional experience. Urology 161:125–130. https://doi.org/10.1016/j.urology.2021.11.020
doi: 10.1016/j.urology.2021.11.020 pubmed: 35007620
Raza SJ, Wilson T, Peabody JO et al (2015) Long-term oncologic outcomes following robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol 68:721–728. https://doi.org/10.1016/j.eururo.2015.04.021
doi: 10.1016/j.eururo.2015.04.021 pubmed: 25985883
Benamran D, Phé V, Drouin SJ et al (2020) Functional outcomes obtained with intracorporeal neobladder after robotic radical cystectomy for cancer: a narrative review. J Robot Surg 14:813–820. https://doi.org/10.1007/s11701-020-01070-x
doi: 10.1007/s11701-020-01070-x pubmed: 32200541
Desai MM, Gill IS (2015) “The devil is in the details”: randomized trial of robotic versus open radical cystectomy. Eur Urol 67:1053–1055. https://doi.org/10.1016/j.eururo.2015.01.017
doi: 10.1016/j.eururo.2015.01.017 pubmed: 25641689
Anceschi U, Maida DIF, Flammia RS et al (2022) Robotic intracorporeal Padua ileal neobladder vs. Florin pouch: comparison of mid-term urodynamic and functional profiles. Minerva Urol Nephrol 74:825–827. https://doi.org/10.23736/S2724-6051.22.04884-4
doi: 10.23736/S2724-6051.22.04884-4 pubmed: 35274904
Di Maida F, Grosso AA, Tasso G et al (2022) Robot assisted radical cystectomy with Florence Robotic Intracorporeal Neobladder (FloRIN): functional and urodynamic features compared with a contemporary series of open Vescica Ileale Padovana (VIP). Eur J Surg Oncol 48:1854–1861. https://doi.org/10.1016/j.ejso.2022.04.007
doi: 10.1016/j.ejso.2022.04.007 pubmed: 35484043
Tuderti G, Mastroianni R, Flammia S et al (2020) Sex-sparing robot-assisted radical cystectomy with intracorporeal Padua ileal neobladder in female: surgical technique, perioperative, oncologic and functional outcomes. J Clin Med 9:577. https://doi.org/10.3390/jcm9020577
doi: 10.3390/jcm9020577 pubmed: 32093240 pmcid: 7073846
Mastroianni R, Ferriero M, Tuderti G et al (2022) Open radical cystectomy versus robot-assisted radical cystectomy with intracorporeal urinary diversion: early outcomes of a single-center randomized controlled trial. J Urol 207:982–992. https://doi.org/10.1097/JU.0000000000002422
doi: 10.1097/JU.0000000000002422 pubmed: 34986007
Mastroianni R, Tuderti G, Anceschi U et al (2022) Comparison of patient-reported health-related quality of life between open radical cystectomy and robot-assisted radical cystectomy with intracorporeal urinary diversion: interim analysis of a randomised controlled trial. Eur Urol Focus 8:465–471. https://doi.org/10.1016/j.euf.2021.03.002
doi: 10.1016/j.euf.2021.03.002 pubmed: 33712389
Mastroianni R, Tuderti G, Ferriero M et al (2023) Open vs robotic intracorporeal Padua ileal bladder: functional outcomes of a single-centre RCT. World J Urol 41:739–746. https://doi.org/10.1007/s00345-023-04312-3
doi: 10.1007/s00345-023-04312-3 pubmed: 36847812
Hautmann RE, Volkmer BG, Schumacher MC et al (2006) Long-term results of standard procedures in urology: the ileal neobladder. World J Urol 24:305–314. https://doi.org/10.1007/s00345-006-0105-z
doi: 10.1007/s00345-006-0105-z pubmed: 16830152
Hautmann RE, Abol-Enein H, Davidsson T et al (2013) ICUD-EAU international consultation on bladder cancer 2012: urinary diversion. Eur Urol 63:67–80. https://doi.org/10.1016/j.eururo.2012.08.050
doi: 10.1016/j.eururo.2012.08.050 pubmed: 22995974
Lombardo R, Mastroianni R, Tuderti G et al (2021) Benchmarking PASADENA consensus along the learning curve of robotic radical cystectomy with intracorporeal neobladder: CUSUM based assessment. J Clin Med 10:5969. https://doi.org/10.3390/jcm10245969
doi: 10.3390/jcm10245969 pubmed: 34945265 pmcid: 8706610

Auteurs

Gabriele Tuderti (G)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Via Elio, Chianesi 53, Rome, Italy. gabriele.tuderti@gmail.com.

Riccardo Mastroianni (R)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Via Elio, Chianesi 53, Rome, Italy.

Giuseppe Chiacchio (G)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Via Elio, Chianesi 53, Rome, Italy.
Urology Unit, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Università Politecnica delle Marche, Ancona, Italy.

Umberto Anceschi (U)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Via Elio, Chianesi 53, Rome, Italy.

Alfredo Maria Bove (AM)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Via Elio, Chianesi 53, Rome, Italy.

Aldo Brassetti (A)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Via Elio, Chianesi 53, Rome, Italy.

Mariaconsiglia Ferriero (M)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Via Elio, Chianesi 53, Rome, Italy.

Leonardo Misuraca (L)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Via Elio, Chianesi 53, Rome, Italy.

Rocco Simone Flammia (RS)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Via Elio, Chianesi 53, Rome, Italy.
Department of Urology, "Sapienza" University of Rome, Rome, Italy.

Flavia Proietti (F)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Via Elio, Chianesi 53, Rome, Italy.

Simone D'Annunzio (S)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Via Elio, Chianesi 53, Rome, Italy.

Costantino Leonardo (C)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Via Elio, Chianesi 53, Rome, Italy.

Salvatore Guaglianone (S)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Via Elio, Chianesi 53, Rome, Italy.

Marianna Anselmi (M)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Via Elio, Chianesi 53, Rome, Italy.

Ashanti Zampa (A)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Via Elio, Chianesi 53, Rome, Italy.

Andrea Benedetto Galosi (AB)

Urology Unit, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Università Politecnica delle Marche, Ancona, Italy.

Giulia Torregiani (G)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Via Elio, Chianesi 53, Rome, Italy.

Michele Gallucci (M)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Via Elio, Chianesi 53, Rome, Italy.

Giuseppe Simone (G)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Via Elio, Chianesi 53, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH